These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3293665)

  • 1. Cell surface effects of human immunodeficiency virus.
    Garry RF; Gottlieb AA; Zuckerman KP; Pace JR; Frank TW; Bostick DA
    Biosci Rep; 1988 Feb; 8(1):35-48. PubMed ID: 3293665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.
    Hoxie JA; Haggarty BS; Bonser SE; Rackowski JL; Shan H; Kanki PJ
    J Virol; 1988 Aug; 62(8):2557-68. PubMed ID: 2839686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
    Sattentau QJ; Moore JP; Vignaux F; Traincard F; Poignard P
    J Virol; 1993 Dec; 67(12):7383-93. PubMed ID: 7693970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion.
    Somasundaran M; Robinson HL
    J Virol; 1987 Oct; 61(10):3114-9. PubMed ID: 2957508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus induces phosphorylation of its cell surface receptor.
    Fields AP; Bednarik DP; Hess A; May WS
    Nature; 1988 May; 333(6170):278-80. PubMed ID: 3259291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.
    Stevenson M; Meier C; Mann AM; Chapman N; Wasiak A
    Cell; 1988 May; 53(3):483-96. PubMed ID: 2966682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion.
    Koenig S; Hirsch VM; Olmsted RA; Powell D; Maury W; Rabson A; Fauci AS; Purcell RH; Johnson PR
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2443-7. PubMed ID: 2784571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-1 (HIV-1) on MOLT-4 cells.
    Kannagi M; Kuroda MJ; Maeda Y; Harada S
    Microbiol Immunol; 1991; 35(9):729-40. PubMed ID: 1687290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human retroviruses: HTLV-I, II, and III and their association with leukemia and AIDS.
    Gurgo C; Gallo RC
    Ann N Y Acad Sci; 1987; 511():350-69. PubMed ID: 2894191
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.
    Salmon P; Olivier R; Riviere Y; Brisson E; Gluckman JC; Kieny MP; Montagnier L; Klatzmann D
    J Exp Med; 1988 Dec; 168(6):1953-69. PubMed ID: 3264318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of human immunodeficiency virus type 1 (HIV-1) with human cells as measured by membrane fluorescence dequenching (DQ) method; roles of HIV-1-cell fusion in AIDS pathogenesis.
    Volsky DJ
    Prog Clin Biol Res; 1990; 343():179-98. PubMed ID: 2198580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
    Smith DH; Byrn RA; Marsters SA; Gregory T; Groopman JE; Capon DJ
    Science; 1987 Dec; 238(4834):1704-7. PubMed ID: 3500514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV heterogeneity and viral pathogenesis.
    Castro BA; Cheng-Mayer C; Evans LA; Levy JA
    AIDS; 1988; 2 Suppl 1():S17-27. PubMed ID: 3147667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.
    LaBonte JA; Patel T; Hofmann W; Sodroski J
    J Virol; 2000 Nov; 74(22):10690-8. PubMed ID: 11044113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.
    Ashorn PA; Berger EA; Moss B
    J Virol; 1990 May; 64(5):2149-56. PubMed ID: 2109100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein.
    Chaudhary VK; Mizukami T; Fuerst TR; FitzGerald DJ; Moss B; Pastan I; Berger EA
    Nature; 1988 Sep; 335(6188):369-72. PubMed ID: 2843774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV.
    Koga Y; Sasaki M; Yoshida H; Wigzell H; Kimura G; Nomoto K
    J Immunol; 1990 Jan; 144(1):94-102. PubMed ID: 2404066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell killing by ultraviolet-inactivated human immunodeficiency virus.
    Rasheed S; Gottlieb AA; Garry RF
    Virology; 1986 Oct; 154(2):395-400. PubMed ID: 3490050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.
    Skinner MA; Langlois AJ; McDanal CB; McDougal JS; Bolognesi DP; Matthews TJ
    J Virol; 1988 Nov; 62(11):4195-200. PubMed ID: 2845130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.